Antimicrobial Agents and Chemotherapy · 1975 · 32 citations · 11 references
Antimicrobial ChemotherapyBacterial PathogensDrug ResistanceVitro Comparison AloneAntimicrobial TherapyAntimicrobial ResistanceBl-p1654 EightHealth SciencesAntibacterial AgentPseudomonas AeruginosaAntimicrobial PharmacokineticsAntimicrobial CompoundPharmacologyClinical MicrobiologyAntimicrobial SusceptibilityAntibioticsMicrobiologyAntimicrobial AgentsPenicillin DerivativesMedicine
Minimum inhibitory concentrations of carbenicillin, ticarcillin, and BL-P1654 were determined for 89 clinical isolates of Pseudomonas aeruginosa. Ticarcillin was generally twice as active and BL-P1654 eight to 16 times as active as carbenicillin. Usually carbenicillin and ticarcillin killed at the same concentration or twice the concentration needed to inhibit, whereas 400 mug of BL-P1654 per ml was not bactericidal for the majority of isolates tested. The inhibitory effect of all three drugs varied markedly with the size of bacterial inoculum. When therapeutically achievable concentrations were used, adding gentamicin enhanced the inhibitory and bactericidal activity of all three penicillin derivatives for the majority of isolates. However, inhibition of isolates highly resistant to gentamicin was not improved by combining the semisynthetic penicillins with gentamicin.
11
Simplified, Accurate Method for Antibiotic Assay of Clinical Specimens
John V. Bennett, Jean L. Brodie, E. Jack Benner et al. · Applied Microbiology · 1966 · 921 citations · Full text
The Hemostatic Defect Produced by Carbenicillin
Clarence H. Brown, Ethan A. Natelson, Wendi Bradshaw et al. · New England Journal of Medicine · 1974 · 192 citations
Platelet Function, Platelet Pathobiology, Pharmacotherapy +17
William A. Altemeier, Joseph C. Todd, WELLFORD W. INGE · Annals of Surgery · 1967 · 144 citations · Full text
D M WEIR · The Lancet · 1964 · 104 citations